Pay in 4 interest-free payments of $5.76 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Mounjaro: Dual Agonist (GIP + GLP-1) Tirzepatide binds to and activates two receptors that play central roles in glucose metabolism and appetite regulation
Excess and chronic consumption of methionine-rich meals overutilizes this metabolic pathway, resulting in excess reactive oxygen species (ROS) production
Cost and Insurance Coverage: These medications can be costly, and insurance coverage may vary
Obesity should be treated like a chronic disease, and patients must continue the medication long-term to sustain the results achieved from the medication
Amputation for soft-tissue sarcoma
Pfizer Accelerates Obesity Pipeline with New GLP-1 Acquisition US Drugmaker Pays $150 Million Upfront for Worldwide Rights to Fosun Unit's Drug, Total Potential Value Reaching $1.93 Billion
US$ 20.01
US$ 20.85
US$ 21.87
US$ 26.00
US$ 24.82
US$ 22.11
US$ 28.53
US$ 25.48
US$ 24.06
US$ 21.80
US$ 25.72
US$ 23.88
US$ 29.80
US$ 28.25
US$ 25.60
US$ 22.77
